Fundraising Fox

Gandeeva

24 employees on LinkedIn · 6 known investors

Find your way into Gandeeva

511 people in our graph share verified history with the Gandeeva team — schools, employers, funds. One of them is your warm intro.

Adrianna Maunlockedknows Sriram Subramaniam · together at Massachusetts Institute of Technology (overlapped)
×9knows the team · via Massachusetts Institute of Technology
×2knows the team · via Indian Institute of Technology Kanpur

Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.

AI & Machine LearningBiotechDeep TechDigital Health

Founders & leadership

SSSriram Subramaniam
Sriram SubramaniaminFounder and CEO, Gandeeva Therapeutics Inc.Sriram Subramaniam is founder and CEO of Gandeeva Therapeutics, which applies cryo-electron microscopy and machine learning to drug discovery. He has over 20 years of experience in structural biology and has led structural biology research groups at the National Institutes of Health and the University of British Columbia.

Investors · 6

Air Street CapitalSt. Peter Port · $500K – $10M
Lux CapitalNew York · $100K – $100M
Obvious VenturesSan Francisco · $250K – $6M
Amgen Venturesreported · 2 sourcesThousand Oaks · $1M – $3M
Leaps by Bayerreported · 2 sourcesLeverkusen

Also in the syndicate · 1

Amplitude Ventures

Funding

SEC filings, press & company announcements

$40M disclosed across 1 of 2 rounds · 2022

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Gandeeva Therapeutics raises $40 million in Series A funding to scale precision imaging techbetakit.com · Feb 2022Gandeeva Therapeutics raises $40m zoom in on biomolecules – and create new drugs in the process | TechCrunchtechcrunch.com · Jan 2022Vancouver-based Gandeeva Raises $51 Million Series-A Funding From Top-Tier Investor Syndicate to Advance AI-Driven Cryo-EM Platform | T-Net Newsbctechnology.com · Jan 2022Gandeeva Raises $40M in Series A Fundingfinsmes.com · Jan 2022Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions - Gandeeva Therapeuticsgandeeva.com · Jan 2022Gandeeva Therapeutics 2/5/2022 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Gandeeva do?
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.
Who founded Gandeeva?
Gandeeva was founded by Sriram Subramaniam.
Who are Gandeeva's investors?
Gandeeva's investors include Air Street Capital, Lux Capital, Obvious Ventures, Amgen Ventures, Leaps by Bayer.
How much funding has Gandeeva raised?
Gandeeva has disclosed $40M raised across 1 of its 2 known rounds.